Ástralía - enska - Department of Health (Therapeutic Goods Administration)

australian pharmaceutical industries pty ltd - biotin,calcium ascorbate,calcium hydrogen phosphate,calcium pantothenate,chromium picolinate,colecalciferol,colloidal anhydrous silica,cyanocobalamin,d-alpha-tocopheryl acid succinate,eleutherococcus senticosus,folic acid,heavy magnesium oxide,hesperidin,inositol,iron amino acid chelate,magnesium amino acid chelate,manganese amino acid chelate,molybdenum trioxide,nicotinamide,potassium iodide,potassium sulfate,pyridoxine hydrochloride,riboflavin,selenomethionine,thiamine nitrate,zinc amino acid -

Kanada - enska - Health Canada

bio agri mix lp - biotin; potassium chloride; sodium chloride; vitamin a; vitamin d3; vitamin e; vitamin b12; vitamin b2; d-pantothenic acid; nicotinic acid; menadione sodium bisulfite; folic acid; thiamine mononitrate; pyridoxine hydrochloride - powder for solution - 18.7mg; 2.5%; 1%; 1870000unit; 280500unit; 1870unit; 3.74mg; 187mg; 1.496g; 4.488g; 748mg; 112.2mg; 224.4mg; 224.4mg - biotin 18.7mg; potassium chloride 2.5%; sodium chloride 1%; vitamin a 1870000unit; vitamin d3 280500unit; vitamin e 1870unit; vitamin b12 3.74mg; vitamin b2 187mg; d-pantothenic acid 1.496g; nicotinic acid 4.488g; menadione sodium bisulfite 748mg; folic acid 112.2mg; thiamine mononitrate 224.4mg; pyridoxine hydrochloride 224.4mg - cattle; cattle; horses; poultry; poultry; swine (pigs)

Kanada - enska - Health Canada

jamp pharma corporation - bacitracin zinc; polymyxin b (polymyxin b sulfate) - ointment - 500unit; 10000unit - bacitracin zinc 500unit; polymyxin b (polymyxin b sulfate) 10000unit - antibiotics

Bandaríkin - enska - NLM (National Library of Medicine)

astrazeneca pharmaceuticals lp - rosuvastatin calcium (unii: 83mvu38m7q) (rosuvastatin - unii:413kh5zj73) - rosuvastatin 5 mg - crestor is indicated: crestor is contraindicated in the following conditions: discontinue crestor when pregnancy is recognized. alternatively, consider the ongoing therapeutic needs of the individual patient. crestor decreases synthesis of cholesterol and possibly other biologically active substances derived from cholesterol; therefore, crestor may cause fetal harm when administered to pregnant patients based on the mechanism of action [see clinical pharmacology (12.1)] . in addition, treatment of hyperlipidemia is not generally necessary during pregnancy. atherosclerosis is a chronic process and the discontinuation of lipid-lowering drugs during pregnancy should have little impact on the outcome of long-term therapy of primary hyperlipidemia for most patients. available data from case series and prospective and retrospective observational cohort studies over decades of use with statins in pregnant women have not identified a drug-associated risk of major congenital malformations. published data from prospect

Bandaríkin - enska - NLM (National Library of Medicine)

h.j. harkins company, inc. - rosuvastatin calcium (unii: 83mvu38m7q) (rosuvastatin - unii:413kh5zj73) - rosuvastatin calcium 20 mg - crestor is indicated as adjunctive therapy to diet to reduce elevated total-c, ldl-c, apob, nonhdl-c, and triglycerides and to increase hdl-c in adult patients with primary hyperlipidemia or mixed dyslipidemia. lipid-altering agents should be used in addition to a diet restricted in saturated fat and cholesterol when response to diet and nonpharmacological interventions alone has been inadequate. pediatric patients 10 to 17 years of age with heterozygous familial hypercholesterolemia (hefh) adjunct to diet to reduce total-c, ldl-c and apob levels in adolescent boys and girls, who are at least one year post-menarche, 10-17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present: ldl-c > 190 mg/dl or > 160 mg/dl and there is a positive family history of premature cardiovascular disease (cvd) or two or more other cvd risk factors. crestor is indicated as adjunctive therapy to diet for the treatment of adult patients with hypertrig

Bandaríkin - enska - NLM (National Library of Medicine)

physicians total care, inc. - rosuvastatin calcium (unii: 83mvu38m7q) (rosuvastatin - unii:413kh5zj73) - rosuvastatin calcium 5 mg - crestor is indicated as adjunctive therapy to diet to reduce elevated total-c, ldl-c, apob, nonhdl-c, and triglycerides and to increase hdl-c in adult patients with primary hyperlipidemia or mixed dyslipidemia. lipid-altering agents should be used in addition to a diet restricted in saturated fat and cholesterol when response to diet and nonpharmacological interventions alone has been inadequate. pediatric patients 10 to 17 years of age with heterozygous familial hypercholesterolemia (hefh) adjunct to diet to reduce total-c, ldl-c and apob levels in adolescent boys and girls, who are at least one year post-menarche, 10-17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present: ldl-c > 190 mg/dl or > 160 mg/dl and there is a positive family history of premature cardiovascular disease (cvd) or two or more other cvd risk factors. crestor is indicated as adjunctive therapy to diet for the treatment of adult patients with hypertrig

Bandaríkin - enska - NLM (National Library of Medicine)

amerisource bergen - bacitracin zinc (unii: 89y4m234es) (bacitracin - unii:58h6rwo52i), neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k), pramoxine hydrochloride (unii: 88ayb867l5) (pramoxine - unii:068x84e056) - bacitracin zinc 500 [iu] in 1 g - first aid to help prevent infection and for the temporary relief of pain or discomfort in minor: - cuts - scrapes - burns

Bandaríkin - enska - NLM (National Library of Medicine)

supervalu inc - bacitracin zinc (unii: 89y4m234es) (bacitracin - unii:58h6rwo52i), neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k), pramoxine hydrochloride (unii: 88ayb867l5) (pramoxine - unii:068x84e056) - bacitracin 500 [iu] in 1 g - first aid to help prevent infection and for the temporary relief of pain or discomfort in - minor cuts - scrapes - burns

Bandaríkin - enska - NLM (National Library of Medicine)

cosette pharmaceuticals, inc. - polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k), neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), bacitracin zinc (unii: 89y4m234es) (bacitracin - unii:58h6rwo52i) - polymyxin b sulfate 5000 [usp'u] in 1 g - first aid antibiotic first aid to help prevent infection in minor • cuts • scrapes • burns

Bandaríkin - enska - NLM (National Library of Medicine)

physicians total care, inc. - bacitracin zinc (unii: 89y4m234es) (bacitracin - unii:58h6rwo52i), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k) - bacitracin zinc 500 [usp'u] in 1 g - for the treatment of superficial ocular infections involving the conjunctiva and/or cornea caused by organisms susceptible to bacitracin zinc and polymyxin b sulfate. this product is contraindicated in those individuals who have shown hypersensitivity to any of its components.